Introduction
The short term benefits of endovascular (EVAR) over open abdominal aortic aneurysm (AAA) repair of decreased mortality, reduced blood loss, shorter hospital stay and improved quality of life 1,2 are balanced by concerns regarding the durability of the procedure, and the occurrence of the EVAR unique complications of endoleak and graft migration. This mandates lifelong surveillance for patients following EVAR in order to ensure continued exclusion of the aneurysm from the circulation. While contrast enhanced computed tomography (CT) is currently the prevalent imaging modality for EVAR surveillance, 3 concerns exist due to the administration of high doses of ionising radiation together with the potential nephrotoxicity of the intravenous contrast. 4 The increased demand for CT by virtually all hospital disciplines means the availability of scanning time is becoming an issue. Identification of an equally accurate, safer, non-invasive and less harmful method of adequately imaging the aorta with a high sensitivity and specificity following EVAR is desirable.
To access continuing medical education questions on this paper, please go to www.vasculareducation.com and click on 'CME' Colour Duplex Ultrasound (CDUS) is an inexpensive, harmless, non-invasive and widely available imaging modality which is the investigation of choice for the screening and surveillance of AAA prior to intervention. 5, 6 Aneurysm sac size and blood flow within the residual aneurysm sac can be determined using CDUS which could therefore be capable of replacing CT as the primary surveillance tool following EVAR. Recent guidelines from the European Society for Vascular Surgery state that CDUS is a safe and sensitive method of endoleak detection, but caution that it should not be a stand alone modality for follow up after EVAR. 7 While others have compared CDUS with CT as a surveillance tool following EVAR, 8, 9 the implications of a potential change to the postoperative follow up algorithm have not been reported. We sought to evaluate the potential cost savings obtained by using CDUS rather than CT as the first line imaging method for post-EVAR surveillance. We also compared the efficacy of the two modalities to ensure that any cost saving would not compromise accuracy of follow up.
Patients & Methods

Patients
Following ethical approval, the CDUS and CT scans of all 145 patients who underwent EVAR at the Mater Hospital from 1st June 2003 to 1st July 2010 were retrospectively reviewed. There were 122 (84.1%) male and 23 (15.8%) female patients with a mean (AESD) age of 77.1 (AE7.9) years. There was no statistical difference between the mean male and female ages. Complete patient demographics and risk factors were available in 141 (97.3%) patients. Deficiencies in the clinical notes in 4 (2.8%) patients meant risk factors could not be assessed. No fenestrated EVARs were performed in the hospital during the timespan of the study.
Following graft implantation all patients underwent regular post operative surveillance, including CDUS and CT scans of the aorta within 7 days of surgery ( Fig. 1 ). After discharge, all patients a CDUS scan at 1 month and then a CDUS scan, and a CT scan, at 6 months, 12 months and annually thereafter provided there was no documented endoleak on either CDUS or CT. Patients who missed scheduled appointments were contacted directly by phone and asked to reattend.
A total of 715 scans were performed on the 145 patients, 426 (59.6%) CDUS and 289 (40.4%) CTs. A mean (AESD) of 2.9 (AE1.9), CDUS scans and 1.9 ((AE1.5) CT scans were performed per patient. Of the total 715 tests performed there were 484 (67.9%) scans available for comparison in 114 (78.6%) of the 145 patients reviewed. The CDUS and CT scans of the remaining 31 (21.4%) patients were not compared due to inconsistent timing of imaging modalities (scans performed greater than 90 days apart were excluded), failure to attend and CT being contra-indicated due to i.v. contrast allergy.
Of the 426 CDUS scans carried out 26 (6.1%) scans were reported as limited, due to the presence of excess bowel gas and body habitus curtailing the determination of residual sac size and endoleak detection. The maximum residual aneurysm size was documented on the remaining 400 (93.9%) CDUS scans. Of the 289 CT's performed 107 (37%) did not have the maximum residual aneurysm sac size documented in the report. The maximum residual aneurysm size was documented on the remaining 182 (63%) of CT scan reports.
Colour duplex ultrasound scanning
All patients were fasted for at least 6 h and scanned in the supine position in a darkened temperature controlled room according to a standard clinical measurement protocol. All scans were performed early in the day to minimise the effect of bowel gas by the same Accredited Vascular Technologist (CG) using a Siemens Sequoia 512 Ultrasound system and later in the study a Siemens S200 Ultrasound system (Siemens AG, Erlangen, Germany). The same 6 mHz curvilinear broadband transducer (range 4 mHze6 mHz) was used to capture all greyscale and Colour Doppler images. In all cases the technologist was blind to the CT results. Any examination that did not achieve complete visualisation of the entire aneurysm sac was considered limited. Contrast was not used in any patient.
All CDUS began with visualisation of the aorta immediately inferior to the diaphragm. The residual aneurysm was imaged in Bmode in both transverse and longitudinal planes from diaphragm to iliac bifurcation. Multiple measurements were obtained of the residual aneurysm sac in the transverse plane ( Fig. 2a ). The maximum measurements of the residual aneurysm sac were recorded and compared to the last scan report to ensure that there was no significant increase in sac size. Careful note was made in Bmode of the stent walls to ensure that there was no evidence of obvious defects or kinking of the metal exoskeleton. The iliac arteries were imaged in B-mode throughout their entire length. Multiple transverse and antero-posterior (AP) measurements were obtained ( Fig. 2b ) and the maximum of the two measurements was recorded for follow up purposes.
The stent and residual aneurysm sac were then assessed using colour flow and spectral Doppler to rule out the presence of an endoleak. This required the use of very sensitive colour flow scale settings to determine the presence of low velocity leaks which may have been present within the residual aneurysm sac (Fig. 2c ). The stent was then reassessed in both transverse and longitudinal planes from diaphragm and to iliac bifurcation. Proximal and distal sealing zones were assessed to ensure that there was no evidence of high jet flow indicating a Type 1 endoleak or low velocity flow within the old aneurysm sac demonstrating forward and reversed flow indicating the presence of a Type 2 endoleak. Blood flow velocity was recorded proximal to the graft, within the body of the graft, at the distal attachment sites and outflow vessels to ensure that there are no flow abnormalities from associated intraluminal defects.
Computed tomography
All CT scans were carried out on a Siemens Somatom Definition AS 128 slice scanner (Siemens AG, Erlangen, Germany) following a standard protocol with 0.75 mm slices and reconstructions performed on all CTs. The maximum residual aneurysm measurement and the presence or absence of an endoleak as reported on the final report was used for comparison. Under our current follow up protocol following EVAR patients undergo 3 CTs in the initial year post graft implantation (post surgery, at 6 months and 1 year) and annually thereafter, provided there has been no documented endoleak or residual sac increase on either CDUS or CT.
Cumulative cost of CT surveillance
The cumulative expenditure on CT surveillance per year following the current algorithm was calculated assuming a cost of V500 per CT scan, based on 2010 costings. Calculating the cumulative number of scans necessary per year assumed that all patients underwent only 1 scan per annum after the first year and that no patient died or was lost to follow up. The reduction in CT cost was then calculated assuming that patients undergo just 1 CT post graft implantation and are then followed up solely with CDUS. The additional cost of providing an abdominal X-ray (V85 based on 2010 costings) as part of a CDUS based surveillance protocol was also taken into account.
Statistical analysis
Sensitivity, specificity, positive predictive value and negative predictive value were calculated for CDUS, taking CT as the gold standard. The patient was considered a false negative if CDUS missed an endoleak that CT detected, a false positive if CDUS detected an endoleak that CT did not; a true positive if the endoleak was detected by both CDUS and CT and a true negative if CDUS and CT documented no endoleak.
The Pearson Coefficient Correlation was performed to assess the strength of the relationship between CDUS and CT in the measurement of the residual aneurysm sac size post repair. All calculations for Pearson coefficient correlation were performed using Windows Microsoft Excel 2007. Level of agreement (LOA) was performed with the method described by Bland and Altman 10 and was calculated using MedCalc statistical software from the means and differences of the two measurements. Accepted value for LOA is between À0.5 and 0.5 cm, which are the values between which 95% of the measured differenced are expected to fall. 11 
Results
Endoleak detection and classification
Of the 484 scans available for comparison (242 pairs) an endoleak was documented on 87 CDUS scans and 25 CTs.
Type 1 endoleaks
There were 5 (2.1%) type 1 endoleaks noted on CDUS, 3 (1.2%) of which were detected on CT and subsequently confirmed by arteriography. There were no type 1 endoleaks noted on CT that were missed on CDUS. Of the two patients who had a type 1 endoleak on CDUS and not on CT, one was an anatomical abnormality and misinterpreted on the CDUS scan. The second patient was documented as a type 2 endoleak on CT. Four of the five patients who had a type 1 endoleak detected on CDUS underwent further intervention.
Type 2 endoleaks
Type 2 endoleaks were detected in 82 (33.9%) of CDUS scans and in 22 (9.0%) of CTs. In no case was a type 2 endoleak detected on CT and not detected on CDUS. Three patients with a documented type 2 endoleak on both imaging modalities underwent further intervention.
Type 3 endoleak
There were no type 3 endoleaks detected in this series on either CT or CDUS. 
Type 4 endoleak
There were no type 4 endoleaks noted in the series on either CT or CDUS.
Endotension
One patient underwent further intervention for endotension. Both imaging modalities documented a significant increase in residual aneurysm sac size. CDUS documented the presence of a type 2 endoleak originating from a lumbar artery but no patent vessel was noted on CT or selective angiography. The patient underwent conversion to open repair where no patent feeding vessel was identified and the sac was plicated over the endograft.
Sensitivity, specificity, positive predictive value and negative predictive value
CDUS was found to have a sensitivity of 100% and a specificity of 85.7% in the detection of endoleaks. The positive predictive value was 28.7% and negative predictive value 100% (Table 1) .
Residual aneurysm sac measurement
Of the 484 scans (242 pairs) available for comparison, the residual AAA sac size was not documented on 15 (6.1%) CDUS scans due to the presence of excess bowel gas and body habitus limiting image quality and on 91 (37%) of the 242 CT scan reports.
This gave a total of 142 (58%) pairs of scans where both the CDUS and the CT could be compared for accuracy in determining the residual AAA diameter post EVAR.
There was no statistically significant difference between the two imaging modalities with mean (AESD) residual AAA diameter on CDUS being 5.5 (AE1.4) and on CT 5.6 (AE1.6) cm (p ¼ 0.99). The Pearson Coefficient correlation was found to be 0.96 indicating a large degree of correlation between CDUS and CT when measuring residual aneurysm size following EVAR (Fig. 3) .
A Bland and Altman plot of the differences against the average of the two measurements of residual aneurysm size post EVAR is presented in Fig. 4 . The mean differences between CDUS and CT are plotted against the mean aneurysmal diameter. The limits of agreement (À0.87e0.75) represents the range within 95% of the differences would be expected to occur, and were calculated as the mean AE 1.96 times the standard deviation of the differences. Just 4 patients (2.8%) fell outside the tolerance interval.
Effect of application of CDUS-first protocol on number and cost of post-EVAR surveillance CTs
In 2010, adopting a protocol where CDUS and AXR was employed as the first line surveillance tool following EVAR would result in a reduction in the number of postoperative CTs required from 235 to 36 ( Fig. 5 ). Based on 2010 costings, this would equate to an estimated reduction in expenditure from V117,500 to V34,915 a saving of V82,585 ( Fig. 6 ).
Discussion
CDUS is universally accepted as the method of choice for both AAA screening and small AAA surveillance. The lack of associated radiation exposure and nephrotoxicity as well as the obvious advantage of being readily available, non-invasive and less expensive make it a more desirable imaging modality for long term surveillance. However, it is largely operator dependant and the quality of images can be adversely affected by the patient's body habitus and excess bowel gas.
Our results show an excellent degree of correlation (r ¼ 0.96) between CDUS and CT in measuring residual aneurysm sac size following EVAR. These results compare favourably to the degree of correlation reported previously by Raman (r ¼ 0.65) and Arko (r ¼ 0.93). 12, 13 The level of agreement was also satisfactory with 95% confidence interval ranging from À0.87e0.75 (Fig. 4 ), although this differs somewhat from the figures previously reported by Sprouse. 11 The incidence of inconclusive CDUS results of 6% in this series is considerably lower than the 25% reported elsewhere 14 and is possibly a reflection of the prolonged 6 h fasting time required prior to CDUS scanning.
The sensitivity of CDUS for the detection of endoleaks of 100% and specificity of 85% differs somewhat to figures reported Table 1 CT and CDUS for endoleak detection. elsewhere in the literature. Sanford reported 67% sensitivity and 91% specificity for CDUS versus CT in the detection of endoleaks with a positive predictive value of between 33 and 100% and negative predictive value of between 91 and 100%. 4 The positive and negative predictive values in this study were similar at 28% and 100% respectively. Arko reported a sensitivity of 81%, a specificity of 95%, a positive predictive value of 94% and a negative predictive value of 90% for CDUS when compared to CT but critically, they documented a small number of endoleaks present on CT that were missed on CDUS. 13 In this study, there were no endoleaks which were detected on CT but missed on CDUS. Manning and colleagues, in a series of 132 patients reported values similar to our own, documenting a 45% positive and 94% negative predictive value for CDUS when compared to CT for postoperative surveillance following EVAR. Specificity of CDUS for endoleak detection was 67% when compared with CTA and sensitivity for CDUS was 86%. Their conclusions were broadly similar, suggesting CDUS as a first line screening tool which allowed selection of a smaller cohort of patients in whom CT was necessary. 8 Henao and colleagues described how CT failed to recognize three type II endoleaks seen by contrast-enhanced ultrasound. 15 A study performed by Civitello and colleagues in 2003 concluded that contrast enhanced CDUS is more accurate than standard CDUS for the detection of endoleaks following AAA repair. 16 As our current scanning protocol has already detected all clinically significant endoleaks it is difficult to see how patient care would be optimised by the use of contrast enhanced ultrasound and thus it has not been adopted as part of our surveillance protocol. Others, however, have reported that the accuracy of contrast-enhanced CDUS was markedly better than CDUS alone and similar to CTA and MRA. 17 Although some have advocated MRI as the surveillance modality of choice following EVAR, 17, 18 this would undoubtedly increase the cost of surveillance and therefore we would regard it as an acceptable second-line imaging tool where CDUS is equivocal or inadequate.
One limitation of CDUS is in the detection of structural abnormalities within the endograft. The replacement of CT with CDUS as a surveillance tool would remove the capability of structural imaging of the endograft using CT reconstruction and thus mandate the inclusion of an abdominal X-ray as part of any new protocol.
While these results suggest that CDUS could be employed as the primary postoperative surveillance tool following EVAR, certain findings should be indications for proceeding to CT, e.g. increase in sac size, detection of high velocity flow within the aneurysm sac suggestive of an endoleak, structural abnormalities in the graft or inability to obtain adequate pictures of the graft with CDUS. On the basis of the very basic calculations contained in this study, adoption of this protocol would lead to a significant reduction in the number of CT scans required as part of the postoperative surveillance programmes with a resultant reduction in exposure to both ionising radiation and intravenous contrast and a significant cost saving. Almost one-third of the cost of postoperative EVAR can be attributed to radiology imaging costs. 19 Beeman reported cost savings of $1595 per patient per year by replacing CT surveillance with CDUS. 19 Conclusion CDUS combined with plain abdominal X-ray could safely replace CT as the primary long term surveillance imaging modality for patients post EVAR, resulting in significant cost-saving without loss of scan accuracy. The identification of abnormalities on the CDUS scan should be the indication to proceed to CT in a smaller group of patients thus reducing the radiation and contrast exposure to the patient and the cost of follow up.
